Results of CRS and Debulking in PMP Patients
This study is ongoing, but not recruiting participants.
Sponsor:
Uppsala University
Information provided by (Responsible Party):
Uppsala University
ClinicalTrials.gov Identifier:
NCT01427101
First received: August 31, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | August 31, 2011 | ||||
| Last Updated Date | August 31, 2011 | ||||
| Start Date ICMJE | September 1993 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE |
Overall survival [ Designated as safety issue: No ] from treatment and forward |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE |
morbidity and mortality [ Time Frame: 90 days ] [ Designated as safety issue: Yes ] mortality is messured during the first 90 postoperative days and morbidity during hospital stay. |
||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Results of CRS and Debulking in PMP Patients | ||||
| Official Title ICMJE | Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei | ||||
| Brief Summary | The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Cross-Sectional |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Patients treated from 1993 are included and during these years treatment strategy has changed. The different strategies are compared but its juts one cohort of patients. No completion date are set due to that reports from other centres show that there are longtime survivers in both treatment groups. |
||||
| Sampling Method | Probability Sample | ||||
| Study Population | Patients with Pseudomyxoma Peritonei, sceduled for surgical treatment at Uppsala University Hospital. |
||||
| Condition ICMJE | Pseudomyxoma Peritonei | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Active, not recruiting | ||||
| Enrollment ICMJE | Not Provided | ||||
| Completion Date | Not Provided | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 20 Years to 80 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Not Provided | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01427101 | ||||
| Other Study ID Numbers ICMJE | 2007/073-PMP-Andréasson | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Uppsala University | ||||
| Study Sponsor ICMJE | Uppsala University | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Uppsala University | ||||
| Verification Date | August 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||